Your browser doesn't support javascript.
loading
ImplemeNting SARS-CoV-2 Rapid antigen testing in the Emergency wArd of a Swiss univErsity hospital: the INCREASE study
Giorgia Caruana; Antony Croxatto; Eleftheria Kampouri; Antonios Kritikos; Onya Opota; Marylin Foerster; Rene Brouillet; Laurence Senn; Reto Lienhard; Adrian Egli; Giuseppe Pantaleo; Pierre-Nicolas Carron; Gilbert Greub.
Afiliação
  • Giorgia Caruana; Lausanne University Hospital and University of Lausanne
  • Antony Croxatto; Lausanne University Hospital and University of Lausanne
  • Eleftheria Kampouri; Lausanne University Hospital and University of Lausanne
  • Antonios Kritikos; Lausanne University Hospital and University of Lausanne
  • Onya Opota; Lausanne University Hospital and University of Lausanne
  • Marylin Foerster; Lausanne University Hospital
  • Rene Brouillet; Lausanne University Hospital
  • Laurence Senn; Lausanne University Hospital and University of Lausanne
  • Reto Lienhard; ADMED
  • Adrian Egli; University Hospital Basel
  • Giuseppe Pantaleo; Lausanne University Hospital
  • Pierre-Nicolas Carron; Lausanne University Hospital
  • Gilbert Greub; Lausanne University Hospital and University of Lausanne
Preprint em Inglês | medRxiv | ID: ppmedrxiv-21250915
Artigo de periódico
Um artigo publicado em periódico científico está disponível e provavelmente é baseado neste preprint, por meio do reconhecimento de similaridade realizado por uma máquina. A confirmação humana ainda está pendente.
Ver artigo de periódico
ABSTRACT
BackgroundWhile facing a second wave in SARS-CoV-2 pandemic, in November 2020 the Swiss Federal Office of Public Health (FOPH) authorized the use of rapid antigen tests (RATs) in addition to the gold-standard reverse transcription-polymerase chain reaction (RT-PCR). MethodsWe implemented the use of RAT in the emergency ward of our university hospital for rapid patients triaging and compared performances of four different antigen tests. All results were compared to SARS-CoV-2 specific RT-PCR (reference standard). ResultsTriaging patients using RAT in association with RT-PCR allowed us to isolate promptly positive patients and to save resources, in a context of rapid RT-PCR reagents shortage. Among 532 patients with valid results, overall sensitivities were 48.3% for One Step Exdia and 41.2% for Standard Q(R), Panbio-and BD Veritor. All four antigen tests exhibited specificity above 99%. Sensitivity increased up to 74.6%, 66.2%, 66.2% and 64.8% for One Step Exdia, Standard Q, Panbio, and BD Veritor respectively, when considering viral loads above 105copies/ml, up to 100%, 97.8%, 96.6% and 95.6% for viral loads above 106 copies/ml and 100% (for all tests) when considering viral loads above 107 copies/ml. Sensitivity was significantly higher for patients presenting with symptoms onset within 4 days (74.3%, 69.2%, 69.2% and 64%, respectively) versus patients with evolution of symptoms for more than 4 days (36.8%, 21.1%, 21.1% and 23.7%, respectively). Sensitivities of all RAT assays were of only 33% among hospitalized patients without COVID-19 symptoms. ConclusionRAT might represent a useful epidemiological resource in selected clinical settings as a complementary tool to the molecular tests for rapid patients triaging, but the lower sensitivity compared to RT-PCR, especially in late presenters and subjects without COVID-19 symptoms, must be taken into account in order to correctly use RAT for triaging.
Licença
cc_no
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Estudo prognóstico Idioma: Inglês Ano de publicação: 2021 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Estudo prognóstico Idioma: Inglês Ano de publicação: 2021 Tipo de documento: Preprint
...